THE NATIONAL ACADEMIES OF SCIENCES, ENGINEERING, AND MEDICINE
Health and Medicine Division
Food and Nutrition Board
Committee on Challenges in Supply, Market Competition, and Regulation
of Infant Formula in the United States
*****
Congressional Briefings
Wednesday, July 24, 2024 – 2:30 p.m.
and
Thursday, August 8, 2024 – 3:00 p.m.
via Zoom
on
Challenges in Supply, Market Competition, and Regulation
of Infant Formula in the United States
Infant formula is a primary or supplementary source of nutrition for many infants in the U.S. Consequently, disruptions to the supply of infant formula can have a severe impact on infants' health and well-being. In late 2021 and early 2022, a recall of specific infant formula products, followed by a pause in production, resulted in a widespread, national shortage.
Requested by Congress in P.L. 117-328, the Consolidated Appropriations Act, 2023, this new report from the National Academies of Sciences, Engineering, and Medicine examines and reports on challenges in supply, market competition, and regulation of infant formula. The resulting consensus study report explains policy and marketplace vulnerabilities that were exposed during the shortage, describes the extent to which actions taken by relevant stakeholders addressed these vulnerabilities, identifies remaining gaps in the system, and recommends actions to reduce the risk and lessen the effect of any future disruption to the infant formula supply chain.
These briefings were for members of Congress and congressional staff only. The report was publicly released on July 25, 2024 and can be found, in its entirety, on the Web site of the National Academies Press.